PharmEasy closes $350-million pre-IPO funding round

Online pharmacy PharmEasy has closed a funding round worth nearly $350 million ahead of filing its draft red herring prospectus (DRHP) before an Initial Public Offering (IPO), according to regulatory documents sourced by ET and people briefed on the matter.

Click here to view the original article.